Shareholder Sarah Russell Appointed to Crohn’s & Colitis Foundation – Michigan Chapter Board
Clayton & McKervey, an international accounting and business advisory firm servicing growth-driven middle-market companies, announces the appointment of Shareholder Sarah Russell, CPA, MBA to the Michigan Chapter board of the Crohn’s & Colitis Foundation. Her appointment was approved during the foundation’s February board meeting.
In her role, Sarah joins 14 directors from metro Detroit who have a strong tie to the foundation’s mission and actively champion for the Crohn’s & Colitis Foundation within the community. According to Sarah, “I was drawn to the foundation’s mission, scope, and innovative approach to engaging supporters; including unique fundraising events, professional conferences, youth camps and family support groups.”
Sarah recently led a Clayton & McKervey team for a football fundraiser at Comerica Park, and will attend the foundation’s 10th Annual Spring into Style Fashion Event on May 18; joining more than 350 guests to raise funds for continued research to find a cure from Crohn’s disease and ulcerative colitis. For information on this event, contact Kiel Porter at [email protected].
“Clayton & McKervey highly values board participation and is proud of Sarah’s commitment to the Crohn’s & Colitis Foundation,” said Robert Dutkiewicz, president of Clayton & McKervey. “We are excited to learn how we may support the organization’s mission in the years to come.”
For the past five decades, the Crohn’s & Colitis Foundation has been at the forefront of research in Crohn’s disease and ulcerative colitis, also known as inflammatory bowel diseases (IBD). The Foundation funds cutting-edge studies at major medical institutions, nurtures investigators at the early stages of their careers, and finances underdeveloped areas of research. Beyond research, the Foundation collaborates with healthcare providers to improve IBD quality of care, as well as educating, supporting, and em-powering patients and their caregivers through patient-centric education and advocacy programs.